Retrospective SARS- CoV-2 human antibody development trajectories are largely sparse and permissive回顾性SARS-CoV-2人抗体发展轨迹在很大程度上是稀疏且允许的。PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12025-01-220OA
Rationalizing Diverse Binding Mechanisms to the Same Protein Fold: Insights for Ligand Recognition and Biosensor DesignACS CHEMICAL BIOLOGYIF3.82024-07-171PRE
An integrated technology for quantitative wide mutational scanning of human antibody Fab librariesNATURE COMMUNICATIONSIF15.72024-05-100OAAI
Common framework mutations impact antibody interfacial dynamics and flexibilityFRONTIERS IN IMMUNOLOGYIF5.92023-02-232OAAI
Regulatory approved monoclonal antibodies contain framework mutations predicted from human antibody repertoiresFRONTIERS IN IMMUNOLOGYIF5.92021-06-229OA